IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

Autor: Rosario Machado-Pinilla, Manuel Nistal, Inmaculada Ibáñez de Cáceres, C. Moratilla, Rosario Perona, Cristobal Belda-Iniesta, Paloma Cejas, Luis Paz-Ares, Cristina Manguan-García, Fernando Lopez-Rios, María Cortes-Sempere, V. Rodriguez-Fanjul, J de Castro-Carpeño
Rok vydání: 2009
Předmět:
Zdroj: Oncogene. 29:1681-1690
ISSN: 1476-5594
0950-9232
DOI: 10.1038/onc.2009.454
Popis: Cisplatin-based chemotherapy is the paradigm of non-small-cell lung cancer (NSCLC) treatment; however, it also induces de novo DNA-hypermethylation, a process that may be involved in the development of drug-resistant phenotypes by inactivating genes required for drug-cytotoxicity. By using an expression microarray analysis, we aimed to identify those genes reactivated in a set of two cisplatin (CDDP) resistant and sensitive NSCLC cell lines after epigenetic treatment. Gene expression, promoter methylation and CDDP-chemoresponse were further analyzed in three matched sets of sensitive/resistant cell lines, 23 human cancer cell lines and 36 NSCLC specimens. Results revealed specific silencing by promoter hypermethylation of IGFBP-3 in CDDP resistant cells, whereas IGFBP-3 siRNA interference, induced resistance to CDDP in sensitive cells (P
Databáze: OpenAIRE